Correlation Between Biotechnology Ultrasector and Calvert Equity

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Calvert Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Calvert Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Calvert Equity Portfolio, you can compare the effects of market volatilities on Biotechnology Ultrasector and Calvert Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Calvert Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Calvert Equity.

Diversification Opportunities for Biotechnology Ultrasector and Calvert Equity

0.79

Correlation Coefficient

Biotechnology Ultrasector  Calvert Equity

Poor diversification

The 3 months correlation between Biotechnology and Calvert is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Calvert Equity Portfolio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calvert Equity Portfolio and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Calvert Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calvert Equity Portfolio has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Calvert Equity go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Calvert Equity

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to generate 2.83 times more return on investment than Calvert Equity. However, Biotechnology Ultrasector is 2.83 times more volatile than Calvert Equity Portfolio. It trades about 0.17 of its potential returns per unit of risk. Calvert Equity Portfolio is currently generating about 0.09 per unit of risk. If you would invest  3,642  in Biotechnology Ultrasector Profund on May 25, 2025 and sell it today you would earn a total of  768.00  from holding Biotechnology Ultrasector Profund or generate 21.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Calvert Equity Portfolio

Biotechnology Ultrasector

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Biotechnology Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.

Calvert Equity Portfolio

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Calvert Equity Portfolio are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Calvert Equity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Ultrasector and Calvert Equity

The main advantage of trading using opposite Biotechnology Ultrasector and Calvert Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Calvert Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calvert Equity will offset losses from the drop in Calvert Equity's long position.

The idea behind Biotechnology Ultrasector Profund and Calvert Equity Portfolio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.